Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?
M Volante, AK Lam, M Papotti, G Tallini - Endocrine pathology, 2021 - Springer
The molecular characterization of poorly and anaplastic thyroid carcinomas has been
greatly improved in the last years following the advent of high throughput technologies …
greatly improved in the last years following the advent of high throughput technologies …
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
Differential MicroRNA‐Signatures in Thyroid Cancer Subtypes
K Santiago, Y Chen Wongworawat… - Journal of Oncology, 2020 - Wiley Online Library
Thyroid cancer is one of the most common endocrine cancers, with an increasing trend in
the last few decades. Although papillary thyroid cancer is the most frequent subtype …
the last few decades. Although papillary thyroid cancer is the most frequent subtype …
Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer
R Samsonov, V Burdakov, T Shtam, Z Radzhabovа… - Tumor Biology, 2016 - Springer
Thyroid cancer (TC) is the most common endocrine malignancy and its incidence has
increased over the last few decades. As has been revealed by a number of studies, TC …
increased over the last few decades. As has been revealed by a number of studies, TC …
Update on molecular testing for cytologically indeterminate thyroid nodules
M Nishino, M Nikiforova - Archives of pathology & …, 2018 - meridian.allenpress.com
Context.—Approximately 15% to 30% of thyroid nodules that undergo fine-needle aspiration
are classified as cytologically indeterminate, presenting management challenges for …
are classified as cytologically indeterminate, presenting management challenges for …
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use
SP Nana-Sinkam, CM Croce - Genome biology, 2014 - Springer
In the past two decades, microRNAs have emerged as crucial mediators of organ
development and human disease. Here, we discuss their role as drivers or suppressors of …
development and human disease. Here, we discuss their role as drivers or suppressors of …
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
A Tessitore, G Cicciarelli, F Del Vecchio, A Gaggiano… - BMC cancer, 2016 - Springer
Background Hepatocellular carcinoma (HCC) is the most common malignant tumor of the
liver. Non-alcoholic fatty liver disease (NAFLD) is a frequent chronic liver disorder in …
liver. Non-alcoholic fatty liver disease (NAFLD) is a frequent chronic liver disorder in …
Pathology of endocrine tumors update: World Health Organization new classification 2017—other thyroid tumors
AK Lam - AJSP: Reviews & Reports, 2017 - journals.lww.com
The data on nonmedullary thyroid tumors in the fourth edition of the World Health
Organization classification of endocrine tumors contain significant revisions. The tumors …
Organization classification of endocrine tumors contain significant revisions. The tumors …
MicroRNAs in the thyroid
M Boufraqech, J Klubo-Gwiezdzinska… - Best Practice & Research …, 2016 - Elsevier
MicroRNAs (miRNAs) are small non-coding RNA comprising approximately 19–25
nucleotides. miRNAs can act as tumour suppressors or oncogenes, and aberrant expression …
nucleotides. miRNAs can act as tumour suppressors or oncogenes, and aberrant expression …
Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma
Y Peng, C Li, DC Luo, JW Ding, W Zhang, G Pan - Molecules, 2014 - mdpi.com
This study screened microRNAs (miRNAs) that are abnormally expressed in papillary
thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC …
thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC …